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Abstract
Background: One of the most useful experimental fibrogenesis models is the “bile duct-ligated rats”. Our aim was
to investigate the quantitative hepatic collagen content by two different methods during the different stages of
hepatic fibrosis in bile duct-ligated rats on a weekly basis. We questioned whether the 1-wk or 4-wk bile duct-
ligated model is suitable in animal fibrogenesis trials.
Methods: Of the 53 male Wistar rats, 8 (Group 0) were used as a healthy control group. Bile duct ligation (BDL)
had been performed in the rest. Bile duct-ligated rates were sacrificed 7 days later in group 1 (10 rats), 14 days
later in group 2 (9 rats), 21 days later in group 3(9 rats) and 28 days later in group 4 (9 rats). Eight rats underwent
sham-operation (Sham). Hepatic collagen measurements as well as serum levels of liver enzymes and function tests
were all analysed.
Results: The peak level of collagen was observed biochemically and histomorphometricly at the end of third week
(P < 0.001 and P < 0.05). Suprisingly, collagen levels had decreased with the course of time such as at the end of
fourth week (P < 0.01 and P < 0.05).
Conclusion: We have shown that fibrosis in bile duct-ligated rats is transient, i.e. reverses spontaneously after 3
weeks. This contrasts any situation in patients where hepatic fibrosis is progressive and irreversible as countless
studies performed by many investigators in the same animal model.
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Background
Hepatic fibrosis is characterized by massive deposition of
extracelluler matrix components in the liver. There are
differences on liver fibrogenesis due to etiological factors
[1].Currently, there are no animal models that completely
mimic the spectrum of the diseases seen in humans.
One of the most useful experimental fibrosis models is
the “bile duct-ligated rats”. There is substantial informa-
tion on morphological changes in the liver of the rats
after obstructive jaundice to date. In 1932, Cameron et
al. described gross macroscopic features and light
microscopical changes in bile duct-ligated rats by inter-
vals from 1/2 hour to 9 weeks [2]. Trams et al. in 1957
and Cameron et al. in 1958 studied functional and
structural disturbances in the bile duct-ligated rats’ liver
[3,4]. Then, several investigators studied serum enzymes
derived from liver cell fraction in the bile duct-ligated
rat in 1972 [5]. Later studies investigated the effect of
biliary obstruction on bile flow and bile acid secretion
[6]. Kountauras et al. surveyed prolonged bile duct
obstruction as a new experimental model for cirrhosis
in the rat and proposed that as a good model for hepatic
fibrosis studies in 1984 [7].
However, none of the previous studies investigated
hepatic collagen content during ongoing and progressive
hepatic fibrosis after bile duct ligation (BDL). Our aim
was to investigate the quantitative hepatic collagen con-
tent by two different methods in bile duct-ligated rats
within the course of time.
Methods
53 male Wistar rats, weighting 244.62 ± 5.03 (mean ±
SE) were included in the study. Eight rats (Group 0)
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Thirty-seven underwent BDL. These animals were sacri-
ficed seven days later in group 1 (n = 10), 14 days later
in group 2 (n = 9), 21 days later in group 3 (n = 9) and
28 days later in group 4 (n = 9).
Eight rats underwent sham-operation (Sham). This
study was approved by the Marmara University, Animal
Use and Care Committee. All the experimental proce-
dure was performed in conformity with the Guiding
Principles for Research Involving Animals. Sacrifice was
performed by decapitation, and trunk blood was
obtained for each. Serum samples were collected for
aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), alkaline phosphatase (ALP), total and
direct bilirubin and gamma-glutamyl transpeptidase
(GGT) measurements, and stored at -80°C.
Bile duct-ligated rats
The operation was performed under ketamine anesthe-
sia. A midline ventral incision was made through the
linea alba. The duodenum was delivered through the
incision in order to place the bile duct under the ten-
sion. Bile duct was isolated. Then, two ligatures were
placed to the proximal portion and one ligature was
placed to the distal part of the bile duct. The ligatures
were tightened. Then, bile duct divided by the scissors
in each. In Shamoperated group ligatures were with-
drawn for leaving the bile duct intact. Then peritoneum,
linea alba and skin were closed with silk.
Liver tissue sampling
T h el e f t ,m i d d l ea n dr i g h tl o b e so fe a c hl i v e rw e r e
explored. We obtained 0.5 × 0.5 × 1.5 cm thick slices
from each lobe randomly. These slices were fixed in
10% buffered formalin and routinely processed and
blocked into the parafin.
Collagen content determination by biochemically
The collagen content of the liver was assayed by the col-
orimetric method described by Lopez de Leon and Roj-
kind [8]. The principle is the coloring of collagenous
protein by Sirius red (36554-8, 2610-10-8; Aldrich Che-
mical, Deisenhofen, Germany) and non-collagenous pro-
teins by fast green (14280; MERCK, Darmstadt,
Germany) (Figure 1). Fifteen micrometer-thick liver
slices were taken from each paraffin block and layered
on glass slides. Slices were deparaffinized after being
incubated by xylol, xylol: ethanol(1:1), ethanol, water:
ethanol, and water. The slides were stained with a satu-
rated solution of picric acid in distilled water containing
0.01% fast green. Each section was kept out of the light
and incubated at room temperature for 15 minutes.
Then, sections were stained by a saturated solution of
picric acid in distilled water containing 0.04% fast green
and 0.1% of sirius red and incubated in the dark room
temperature for 30 minutes. Then, samples were rinsed
and transferred to a test tube containing 1 ml of 0.1%
NaOH in absolute methanol (1:1). The tubes were
gently mixed until the color was eluted completely.
Absorbance of the eluted color was read at 540 and 605
nm by a Jasco V 50 UV-VIS spectrophotometer. Maxi-
mal absorbance of fast green is at 630 nm and 540 nm
for Sirius red. Fast green exhibites a small absorbance
(7.78%) at 540 nm. This interference remains constant
at different concentrations of fast green. By contrast, sir-
ius red has no absorbance at 630 nm. Therefore, sirius
red does not interfere with non-collagenous protein
determination. Collagen content of tissue was calculated
using the formula below. It was described as in micro-
gram collagen per milligram protein [8].
µg collagen/mg total proteins = µg collagen/

mg collagen + mg non − collagenaous protein

mg collagen = absorbance 540 nm − 7.78% absorbance 630 nm
non − collagenous proteins = absorbance 630
Histomorphometric collagen measurement
Four μ slices were obtained from the paraffin blocks and
stained by tricrome. We used a special image analysis
software for histomorphometric measurements. It was
referred to as “staining” that can perform automatic
threshold which was written by an optical image analysis
expert under a commercially available software
‘Matlab
®’ (Natick, Massachusetts/USA). We used an
automated histogram threshold method for measure-
ments. We took the pictures by 40 × objective of an
Olympus
® microscope (Hamburg/Germany) with a
Nicon
® digital camera. 120 consecutive pictures from
each slice were obtained. Each of these frames was
Figure 1 Sirius red and fast green-stained liver sections
showed prominent bile duct proliferation and fibrosis (× 20).
Sirius red stained collagenous proteins. Fast green stained non-
collagenous proteins.
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2)a r e ao ft h e
liver. 120 frames were used to reach 1 cm 2 of total sur-
face. Image analysis software was run to automatically
outline and to calculate the sum of green spectrum
stained fibrotic area over red background. The collage-
nous areas were measured as a percentage of the total
surface area of the liver.
Histopathological investigations
Five-micrometer liver sections were stained by hematoxy-
lin-eosin and Masson’s trichrom. We used Ishak fibrosis
classification system for grading of necroinflammatory
activity and staging of fibrosis [9]. We used a scoring system
from 1 to 4 for grading of portal proliferation (Figure 2).
Serum measurements
Serum AST and ALT levels were assessed by using
commercial kits (Roche Diagnostics, GmbH, D-68298,
Mannheim, Germany) in Roche-Hitachi Modular Autoa-
nalyzer (Roche Diagnostics, GmbH, D-68298, Man-
nheim, Germany).Bayer Opera autoanalyzer was used to
measure bilirubin levels by wavelength, 550 nm; tem-
perature, 37°C; and instrument set for endpoint with
sample blanking mode. Serum levels of GGT and ALP
were measured by an Olympus AU 800 biochemical
automated analyser.
Statistic analysis
Kruskall-Wallis test was used to analyse the homogenity
among the different groups of rats, Additionally, multi-
ple post-hoc comparisons with Mann-Whitney U test
was used. P value less than 0.05 was considered to be
statistically significant. Calculation was performed by
SPSS in v.11 program.
Results
Body weight
There were no significant differences about the body
weights between the groups at any time. The animals
slightly lost weight at the 1st week. They gained weight
during the 2nd week. These changes never reached a
difference between BDL rats, sham group and control
group (Table 1)
Liver weight
Liver weight increased at the 1st week, and continued to
increase during the study. There was no significant dif-
ference between controls and group 1. By contrast,
there were statistically significant differences between
control groups and groups 2, 3 and 4 (P < 0.001) (Table
1).
Histopathological findings
There were some differences in necroinflammatuary
scores (NIS) and fibrosis scores (FS) among the groups.
NIS and FS were higher in group 3 than in others
(groups 1, 2 and 4). However, these differences were not
significant, statistically (P > 0.05). Portal proliferation
has been increased from the first week to the fourth
week. The peak level of portal proliferation was
observed at the end of the fourth week.
Biochemical hepatic collagen measurement
The hepatic collagen content of BDL groups was signifi-
cantly higher than healthy controls and sham group. Col-
lagen content of the liver with bile duct-ligated was
increased, particularly, between control group and group 1
at the 1st week (P < 0.001). The collagen content of the
liver was higher at the 2nd week; with a statistically signifi-
cant difference between control group and group 2. There
was no difference between groups 1 and 2 (P > 0.05). At
the 3rd week, the collagen content reached to maximum
concentration in the Group 3 and compared to other
groups (control, group 1, 2, and 4 and sham) (P < 0.001).
Moreover, we found a statistically significant decreasing in
group 4 at the 4th week (P < 0.01) (Figure 3).
Histomorphometric collagen measurement
Histomorhometric measurement for collagen demon-
strated a very similar pattern as the biochemical col-
lagen measurement. We found that the peak level of
collagen was at the third week and a decrease at the
fourth week (P < 0.05) (Figure 4).
Serum levels of AST and ALT
Serum AST levels increased up to 5 fold of normal at
the 1st week. It was started to decrease at the 2nd week,
but it was still higher by two fold than control groups at
the end of the fourth week (P < 0.001). Serum ALT
Figure 2 Tricrome stained section showed portal-portal fibrosis
(×40). Green areas were fibrotic and red areas were normal.
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1) when compared with the control group. It started to
decrease at the 2nd week. But, serum ALT level was still
two times higher than control group at the 4th week
(Figure 5).
Serum bilirubin concentrations
Serum total bilirubin level reached to the level of 17.42
mg/dl ± 4.66 (mean ± SD) in group 1 and was almost
the same level in group 2 (p > 0.05). The bilirubin level
started to decrease in group 3, but it was still high at
the 4th week (group 4) (8.81 ± 2.76 mg/dl). Direct bilir-
ubin levels increased in the same manner and 10.15 ±
2.77 mg/dl in Group1. However, there was no statisti-
cally significant difference between groups 1 and 2 (P >
0.05). Then, it started to decrease but was still higher at
the 4th week (5.28 ± 1.69) (Figure 6).
Serum levels of ALP and GGT
Serum ALP level increased up to 5 fold of normal at the
1st week. It started to decrease at the 2nd week. It was
still higher at the 4 th week, and no significant
difference between control group and group 4 (P >
0.05). Serum GGT level increased up to 20 times and
reached to 51.12 ± 35.60. It continued to increase and
reached to its maximum concentration at the third week
(95.22 ± 48.97). At the end of fourth week it decreased
to 47 ± 20. 97 (Figure 7).
Discussion
There is no animal fibrosis model that completely
mimics the spectrum of the diseases seen in human so
far [10]. Previously, many investigators used a 4-week
bile duct ligated rat model in fibrosis studies [1-18].
Each model facilitated our understanding underlying
cellular and molecular mechanisms of fibrogenesis and
further assessment of the efficacy of various antifibrotic
agents. Our aim was to investigate the quantitative
hepatic collagen content with the levels of the serum
liver enzymes during the different stages of hepatic
fibrosis in bile duct-ligated rats.
In the presented study, we found collagen peak at the
third week after bile duct ligation by utilizing both
Table 1 Mean body and liver weights were shown
Body weights at the beginning of the study Body weights at the end of the study Liver weight after sacrifice
N Mean SD Mean SD Mean SD
Control 8 254.71 31.98 293.28 35.71 9.78 0.52
Sham 8 239.42 30.08 298.00 38.71 10.44 0.93
Group 1 10 235.12 20.35 181.25* 35.48 10.76 2.00
Group 2 9 227.75 34.52 233.12 37.030 13.02** 1.77
Group 3 9 251.88 29.78 265.22 42.29 16.00** 1.31
Group 4 9 258.87 38.09 271.62 41.92 16.62** 3.77
*Body weight decreased significantly in group1 (P < 0.01).
**Liver weight increased in groups 2, 3 and 4 compared to control, sham and group 1 (P < 0.01).
Figure 3 Hepatic collagen content increased significantly in
BDL groups compared to the control and sham groups (P <
0.001). There was a difference between liver collagen content of
the third group compared to groups 1, 2 and 4 (P < 0.01).
Figure 4 There was a significant increase in hepatic collagen
amount in BDL groups histomorphometricaly compared to the
control and sham groups (P < 0.01). Collagen peak was found at
the end of the third week when compared to the groups 1, 2 and
4 (P < 0.05).
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collagen measurement. Since these results were unex-
pected, we re-validated our results in both groups 3 and
4 by repating examinations. We re-measured the hepatic
collagen concentration in revalidation study and found
that the hepatic collagen of the third group was higher
than the fourth group again. The correlation between
liver collagen content of earlier group 3-4 and new
group 3-4 was r: 0.92 (P < 0.001).
Serum ALP levels were increased in the first week,
then they started to decrease. Finally, serum ALP level
was the same as the control group at the fourth week.
Similarly, serum GGT level reached its peaks value in
the third week and at the end of the fourth week they
were still higher. These results were reflecting the
changes on the bile ducts in bile ductligated rat model
and in a correlation with measured hepatic collegen
concentrations. Having these results, we decided to sur-
vey the earlier studies to better elucidate who will use
this experimental method. Bile duct ligation model has
attracted many investigators and many studies in rats as
well as other animals performed to clarify this model
[1]. The most outstanding and comprehensive study in
BDL was performed by Cameron and Oakley in 1932
[2]. They used 120 rats and investigated them from one
hour to 9 weeks. They found increased hepatic fibro-
blastic proliferation starting by day 4 and perilobuler
cirrhosis 47 days after bile duct ligation and further
frank cirrhosis at the 61st day.
Cameron and Hassan evaluated the structural and
functional disturbances in bile ductligated rat and
observed them from 1/2 hour to 11 weeks. They found
the same structural disturbances as their former study
[4]. The serum bilirubin levels were increased to 10.5
mg at the first week which was less than what was
observed by us. Then, it was decreased to 4. 8 mg at the
4th weeks, the serum bilirubin fluctuated from week 5
through week 11 in this previous study. Trams et al.
evaluated the morphological and functional changes in
the liver of rats both after ligation (without division)
and excision of the common bile duct [3]. The rats were
sacrificed after 1., 3., 14. and 28. days. Fibrous tissue
was established around the duct at the 14th and 28th
days in CBD excised rats. However, in bile duct-ligated
(without division) rats they determined approximately
95% recanalization and normalization of the bile duct.
Johnstone et al. reported a quantitave assessment of the
Figure 5 Serum ALT levels increased in groups 2, 3 and 4
compared to the control and the sham groups: P < 0.01 for
groups 2 and 3, P < 0.01 for group 4. Serum AST levels increased
in groups 1, 2, 3 and 4 compared to the control and sham group (P
< 0.001).
Figure 6 Serum bilirubin levels increased in groups 1, 2, 3 and
4 compared to the control and sham groups (P < 0.001).
Figure 7 ALP leves were increased at the end of the first week.
Then, it was decreased to the normal level at the end of the fourth
week. The peak level of serum GGT was found at the end of the
third week.
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ligation and investigated them from first day to 40 days
[19]. Volume proportion of parenchyma, bile duct and
supportive stroma were 97/2/1% in sham operated rats,
respectively and 37/42/20% respectively at the 40 days
after BDL without cirrhosis.
The most controversial area in BDL model is the
degree or amount of hepatic fibrosis. Kountauaras et al
sacrificed rats 5, 10, 15, and 28 days after BDL and
found that all rats had cirrhosis at the 28th day. Several
reported frank cirrhosis developed after 3 or 5 weeks
[2-12]. On the other hand, there are several studies that
did not show any evidence of cirrhosis even at the 40th
day following bile duct ligation in the rat [5,20-22]. We
did not see cirrhosis in the presented study and our for-
mer studies after 28 days bile duct-ligation [23-28]. We
observed grades 2 nd 3 fibrosis in our studies. Previously
reported that cirrhosis in BDL rats occurs earliest 4-6
weeks after ligation [27,28]. The reason for the differ-
ences is unclear and needs further clarification.
Conclusions
We have shown that fibrosis in bile duct-ligated rats is
transient, i.e. reverses spontaneously after 3 weeks both
biochemically and histomorphometrically. This contrasts
any situation in patients where hepatic fibrosis is progres-
sive and irreversible as countless studies performed by
many investigators in the same animal model. In fact, it
has been assumed to date, that hepatic fibrosis in patients
and animal models progresses to cirrhosis, but does not
reverse spontaneously as described in the manuscript.
Although markers of fibrosis and liver damage
declined after the 3-week peak, they still remained ele-
vated 4 weeks after ligation, compared to control groups
in this study. Thus, this animal model may in fact be
suitable to study fibrosis and experimental therapies,
provided that correct untreated control groups are
included.
Our results are fundamental because many investiga-
tors use four-week bile ductligated rats for hepatic fibro-
sis and antifibrotic therapy studies. To see the effect of
antifibrotic therapy on maximum level of collagen is
important. Understanding the dynamics of hepatic fibro-
genesis we have to use three and four week bile duct-
ligated rat models together. We need further studies to
clarify the results of the study.
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